Form D · Other Health Care

Cytrellis Biosystems, Inc.

Woburn, MA · CIK 0001564079

Offering snapshot reported Dec 31, 2024 · SEC filing

Reported sold
$25.1M
Offering amount: $32.1M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 20, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 31, 2024Initial$25,132,486No comparison15SEC filing
Jan 4, 2021Initial$49,999,998No comparison14SEC filing
Feb 20, 2015Initial$7,139,937No comparison21SEC filing
Dec 12, 2012Initial$450,000No comparison3SEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-533919

Source: Form D, filed Dec 31, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
R. Rox Anderson Director
Fred Aslan, Md Director
Frederick Beddingfield Iii, Md Director
Keith Crandall Director
Keith L. Crandell Director
Karen Cronholm Director, Executive
David Cruikshank Director
Douglas A. Levinson Director, Executive
Diane Marcou Executive
John Mcdonough Director
John Mc Donough Director, Executive
Amit Munshi Director
Michael Peterson Director
David Stone Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
34 Commerce Way
Woburn, MA, 01801